Candel Therapeutics Inc (CADL) — Financial Flexibility Index
Candel Therapeutics Inc (CADL) has a Financial Flexibility Index of -0.27x as of March 2026. Free cash flow of $-17.36 Million (operating CF $-18.04 Million minus capex $675.00K) represents 0% of total liabilities ($63.89 Million). Check how strategically is Candel Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Candel Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Candel Therapeutics Inc across 7 annual periods. See working capital position of Candel Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Candel Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Candel Therapeutics Inc. For the full company profile including market capitalisation, see CADL market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | $-37.72 Million | $-38.31 Million | $73.27 Million | ▲ +22.7% |
| 2024 | -0.67x | $-27.01 Million | $-27.02 Million | $40.54 Million | ▲ +43.9% |
| 2023 | -1.19x | $-33.79 Million | $-34.24 Million | $28.46 Million | ▼ -21.4% |
| 2022 | -0.98x | $-30.12 Million | $-31.42 Million | $30.80 Million | ▼ -20.3% |
| 2021 | -0.81x | $-20.38 Million | $-22.22 Million | $25.07 Million | ▼ -562.1% |
| 2020 | -0.12x | $-7.59 Million | $-9.07 Million | $61.84 Million | ▼ -32.0% |
| 2019 | -0.09x | $-5.02 Million | $-5.18 Million | $53.94 Million | — |